Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermal Administration”

817 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 817 results

Not applicableNot Yet RecruitingNCT07317037
What this trial is testing

ActiTENS Mini (Transcutaneous Electrical Stimulation) in Women With Chronic Pain From Pelvic Endometriosis

Who this might be right for
Endometriosis
Assistance Publique - Hôpitaux de Paris 208
Not applicableStudy completedNCT04998331
What this trial is testing

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, Cutaneous
Takeda 51
Testing effectiveness (Phase 2)Study completedNCT00961220
What this trial is testing

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Who this might be right for
Recurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaStage I Mycosis Fungoides and Sezary Syndrome AJCC v7Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Study completedNCT00300222
What this trial is testing

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Who this might be right for
Peripheral Nervous System DiseasesPainNeuralgia+2 more
NeurogesX 400
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Testing effectiveness (Phase 2)UnknownNCT04296786
What this trial is testing

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Who this might be right for
Cutaneous T-cell Lymphoma
Peking Union Medical College Hospital 52
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00129428
What this trial is testing

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Who this might be right for
KeloidScleroderma, LocalizedAcne Keloidalis+2 more
University of Michigan 33
Not applicableStudy completedNCT06113081
What this trial is testing

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Study completedNCT00317681
What this trial is testing

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Heinrich-Heine University, Duesseldorf 30
Not applicableLooking for participantsNCT06455475
What this trial is testing

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Who this might be right for
Diabetic Foot Ulcer
Capsicure, LLC 150
Large-scale testing (Phase 3)Study completedNCT01541930
What this trial is testing

An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours

Who this might be right for
Malodorous Infected Cutaneous Ulcer
Galderma R&D 21
Testing effectiveness (Phase 2)WithdrawnNCT00731757
What this trial is testing

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

Who this might be right for
SarcoidosisCutaneous Sarcoidosis
Wright State University
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Ended earlyNCT01419795
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Fred Hutchinson Cancer Center 3
Load More Results